Cargando…
Diabetic cardiomyopathy: prevalence, determinants and potential treatments
The prevalence of type 2 diabetes (T2D) has reached a pandemic scale. These patients are at a substantially elevated risk of developing cardiovascular disease, with heart failure (HF) being a leading cause of morbidity and mortality. Even in the absence of traditional risk factors, diabetes still co...
Autores principales: | Gulsin, Gaurav S., Athithan, Lavanya, McCann, Gerry P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437329/ https://www.ncbi.nlm.nih.gov/pubmed/30944723 http://dx.doi.org/10.1177/2042018819834869 |
Ejemplares similares
-
Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date
por: Athithan, Lavanya, et al.
Publicado: (2019) -
MECHANISMS IN ENDOCRINOLOGY: Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review
por: Levelt, Eylem, et al.
Publicado: (2018) -
Cardiovascular and systemic determinants of exercise capacity in people with type 2 diabetes mellitus
por: Bilak, Joanna M., et al.
Publicado: (2021) -
Sex and ethnic differences in the cardiovascular complications of type 2 diabetes
por: Yeo, Jian L., et al.
Publicado: (2021) -
The impact of lifestyle intervention on left atrial function in type 2 diabetes: results from the DIASTOLIC study
por: Alfuhied, Aseel, et al.
Publicado: (2022)